Granulocytic myeloid-derived suppressor cells accumulate in human placenta and polarize toward a Th2 phenotype

Journal of Immunology

Volumn 196, Issue 3, 2016, Pages 1132-1145

  Kostlin, Natascha ^a   Hofstadter, Kathrin ^a   Ostermeir, Anna Lena ^a   Spring, Barbel ^a   Leiber, Anja ^a   Haen, Susanne ^a   Abele, Harald ^a   Bauer, Peter ^a   Pollheimer, Jurgen ^b   Hartl, Dominik ^c   Poets, Christian F ^a   Gille, Christian ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE 1; CHEMOKINE RECEPTOR CXCR4; REACTIVE OXYGEN METABOLITE;

ADULT; ARTICLE; BONE MARROW CELL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; FEMALE; GRANULOCYTIC MYELOID DERIVED SUPPRESSOR CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE PROLIFERATION; MOTHER FETUS RELATIONSHIP; NEWBORN; POLARIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPONTANEOUS ABORTION; SUPPRESSOR CELL; TH2 CELL; TROPHOBLAST; ADOLESCENT; CELL DIFFERENTIATION; FLOW CYTOMETRY; GRANULOCYTE; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; PHENOTYPE; PLACENTA; PREGNANCY; YOUNG ADULT;

ABORTION, SPONTANEOUS; ADOLESCENT; ADULT; CELL DIFFERENTIATION; FEMALE; FLOW CYTOMETRY; GRANULOCYTES; HUMANS; IMMUNE TOLERANCE; IMMUNOHISTOCHEMISTRY; MYELOID CELLS; PHENOTYPE; PLACENTA; PREGNANCY; TH2 CELLS; YOUNG ADULT;

EID: 84957644180     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1500340     Document Type: Article

References (67)

1. Bansal, A. S. 2010. Joining the immunological dots in recurrent miscarriage. Am. J. Reprod. Immunol. 64: 307-315.
2. Goldenberg, R. L., J. F. Culhane, J. D. Iams, and R. Romero. 2008. Epidemiology and causes of preterm birth. Lancet 371: 75-84.
3. McCormick, M. C. 1985. The contribution of low birth weight to infant mortality and childhood morbidity. N. Engl. J. Med. 312: 82-90.
4. Lee, S. K., J. Y. Kim, M. Lee, A. Gilman-Sachs, and J. Kwak-Kim. 2012. Th17 and regulatory T cells in women with recurrent pregnancy loss. Am. J. Reprod. Immunol. 67: 311-318.
5. Warning, J. C., S. A. McCracken, and J. M. Morris. 2011. A balancing act: mechanisms by which the fetus avoids rejection by the maternal immune system. Reproduction 141: 715-724.
6. Arck, P. C., and K. Hecher. 2013. Fetomaternal immune cross-talk and its consequences for maternal and offspring's health. Nat. Med. 19: 548-556.
7. Erlebacher, A. 2013. Mechanisms of T cell tolerance towards the allogeneic fetus. Nat. Rev. Immunol. 13: 23-33.
8. Saito, S., A. Nakashima, T. Shima, and M. Ito. 2010. Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy. Am. J. Reprod. Immunol. 63: 601-610.
9. H2 phenomenon? Immunol. Today 14: 353-356.
10. Gabrilovich, D. I., and S. Nagaraj. 2009. Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9: 162-174.
11. Mauti, L. A., M. A. Le Bitoux, K. Baumer, J. C. Stehle, D. Golshayan, P. Provero, and I. Stamenkovic. 2011. Myeloid-derived suppressor cells are implicated in regulating permissiveness for tumor metastasis during mouse gestation. J. Clin. Invest. 121: 2794-2807.
12. Rodriguez, P. C., M. S. Ernstoff, C. Hernandez, M. Atkins, J. Zabaleta, R. Sierra, and A. C. Ochoa. 2009. Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes. Cancer Res. 69: 1553-1560.
13. Youn, J. I., S. Nagaraj, M. Collazo, and D. I. Gabrilovich. 2008. Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J. Immunol. 181: 5791-5802.
14. Brandau, S., S. Trellakis, K. Bruderek, D. Schmaltz, G. Steller, M. Elian, H. Suttmann, M. Schenck, J. Welling, P. Zabel, and S. Lang. 2011. Myeloid-derived suppressor cells in the peripheral blood of cancer patients contain a subset of immature neutrophils with impaired migratory properties. J. Leukoc. Biol. 89: 311-317.
15. + population induces T cell suppression and Th2 polarization in sepsis. J. Exp. Med. 204: 1463-1474.
16. Rieber, N., A. Brand, A. Hector, U. Graepler-Mainka, M. Ost, I. Schäfer, I. Wecker, D. Neri, A. Wirth, L. Mays, et al. 2013. Flagellin induces myeloid-derived suppressor cells: implications for Pseudomonas aeruginosa infection in cystic fibrosis lung disease. J. Immunol. 190: 1276-1284.
17. + myeloid suppressor cells cause T cell dysfunction after traumatic stress. J. Immunol. 176: 2085-2094.
18. Luyckx, A., E. Schouppe, O. Rutgeerts, C. Lenaerts, C. Koks, S. Fevery, T. Devos, D. Dierickx, M. Waer, J. A. Van Ginderachter, and A. D. Billiau. 2012. Subset characterization of myeloid-derived suppressor cells arising during in-duction of BM chimerism in mice. Bone Marrow Transplant. 47: 985-992.
19. Wang, Y., X. Gu, J. Xiang, and Z. Chen. 2012. Myeloid-derived suppressor cells participate in preventing graft rejection. Clin. Dev. Immunol. 2012: 731486.
20. Greten, T. F., M. P. Manns, and F. Korangy. 2011. Myeloid derived suppressor cells in human diseases. Int. Immunopharmacol. 11: 802-807.
21. Zea, A. H., P. C. Rodriguez, M. B. Atkins, C. Hernandez, S. Signoretti, J. Zabaleta, D. McDermott, D. Quiceno, A. Youmans, A. O'Neill, et al. 2005. Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion. Cancer Res. 65: 3044-3048.
22. Rieber, N., C. Gille, N. Köstlin, I. Schäfer, B. Spring, M. Ost, H. Spieles, H. A. Kugel, M. Pfeiffer, V. Heininger, et al. 2013. Neutrophilic myeloid-derived suppressor cells in cord blood modulate innate and adaptive immune responses. Clin. Exp. Immunol. 174: 45-52.
23. Köstlin, N., H. Kugel, B. Spring, A. Leiber, A. Marmé, M. Henes, N. Rieber, D. Hartl, C. F. Poets, and C. Gille. 2014. Granulocytic myeloid derived sup pressor cells expand in human pregnancy and modulate T-cell responses. Eur. J. Immunol. 44: 2582-2591.
24. Lechner, M. G., D. J. Liebertz, and A. L. Epstein. 2010. Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells. J. Immunol. 185: 2273-2284.
25. + myeloid-derived suppressor cell subsets induced from peripheral blood mono-nuclear cells co-cultured with a diverse set of human tumor cell lines. J. Transl. Med. 9: 90.
26. Raghupathy, R. 2001. Pregnancy: success and failure within the Th1/Th2/Th3 paradigm. Semin. Immunol. 13: 219-227.
27. Sykes, L., D. A. MacIntyre, X. J. Yap, T. G. Teoh, and P. R. Bennett. 2012. The Th1:Th2 dichotomy of pregnancy and preterm labour. Mediators Inflamm. 2012: 967629.
28. Hill, J. A., K. Polgar, and D. J. Anderson. 1995. T-helper 1-type immunity to trophoblast in women with recurrent spontaneous abortion. JAMA 273: 1933-1936.
29. Raghupathy, R., M. Makhseed, F. Azizieh, N. Hassan, M. Al-Azemi, and E. Al-Shamali. 1999. Maternal Th1 - And Th2-type reactivity to placental antigens in normal human pregnancy and unexplained recurrent spontaneous abortions. Cell. Immunol. 196: 122-130.
30. Acosta-Rodriguez, E. V., L. Rivino, J. Geginat, D. Jarrossay, M. Gattorno, A. Lanzavecchia, F. Sallusto, and G. Napolitani. 2007. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat. Immunol. 8: 639-646.
31. + T cells are highly permissive to HIV-1 infection. J. Immunol. 184: 1604-1616.
32. + regulatory T cells and T helper 1, T helper 2, and T helper 17 cells in human early pregnancy decidua. Biol. Reprod. 82: 698-705.
33. hi suppressive monocytes in experimental autoimmune encephalomyelitis. J. Immunol. 179: 5228-5237.
34. 2 regulatory T-cell populations are enriched in human early normal pregnancy decidua: a phenotypic study of paired decidual and peripheral blood samples. Am. J. Reprod. Immunol. 66(Suppl. 1): 44-56.
35. bright regulatory T cells and CTLA-4 expression in peripheral and decidual lymphocytes are down-regulated in human miscarriage. Clin. Immunol. 133: 402-410.
36. Nair, R. R., P. Sinha, A. Khanna, and K. Singh. 2015. Reduced myeloid-derived suppressor cells in the blood and endometrium is associated with early miscarriage. Am. J. Reprod. Immunol. 73: 479-486
37. Zhao, H., F. Kalish, S. Schulz, Y. Yang, R. J. Wong, and D. K. Stevenson. 2015. Unique roles of infiltrating myeloid cells in the murine uterus during early to midpregnancy. J. Immunol. 194: 3713-3722.
38. Agaugué, S., E. D. Carosella, and N. Rouas-Freiss. 2011. Role of HLA-G in tumor escape through expansion of myeloid-derived suppressor cells and cyto-kinic balance in favor of Th2 versus Th1/Th17. Blood 117: 7021-7031.
39. Filipazzi, P., R. Valenti, V. Huber, L. Pilla, P. Canese, M. Iero, C. Castelli, L. Mariani, G. Parmiani, and L. Rivoltini. 2007. Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine. J. Clin. Oncol. 25: 2546-2553.
40. 2-driven induction and maintenance of cancer - Associated myeloid-derived suppressor cells. Immunol. Invest. 41: 635-657.
41. 2-induced CXCL12 production and CXCR4 expression controls the accumulation of human MDSCs in ovarian cancer environment. Cancer Res. 71: 7463-7470.
42. Hanna, J., O. Wald, D. Goldman-Wohl, D. Prus, G. Markel, R. Gazit, G Katz, R. Haimov-Kochman, N. Fujii, S. Yagel, et al. 2003. CXCL12 expression by invasive trophoblasts induces the specific migration of CD16 human natural killer cells. Blood 102: 1569-1577.
43. Piao, H. L., Y. Tao, R. Zhu, S. C. Wang, C. L. Tang, Q. Fu, M. R. Du, and D. J. Li. 2012. The CXCL12/CXCR4 axis is involved in the maintenance of Th2 bias at the maternal/fetal interface in early human pregnancy. Cell. Mol. Immunol. 9: 423-430.
44. Murdoch, C, and A. Finn. 2000. Chemokine receptors and their role in inflammation and infectious diseases. Blood 95: 3032-3043.
45. Saito, S., T. Kasahara, S. Sakakura, H. Umekage, N. Harada, and M. Ichijo. 1994. Detection and localization of interleukin-8 mRNA and protein in human placenta and decidual tissues. J. Reprod. Immunol. 27: 161-172.
46. bright natural killer cells in the human early pregnancy decidua. Biochem. Biophys. Res. Commun. 200: 378-383.
47. Pitman, H., B. A. Innes, S. C. Robson, J. N. Bulmer, and G. E. Lash. 2013. Altered expression of interleukin-6, interleukin-8 and their receptors in decidua of women with sporadic miscarriage. Hum. Reprod. 28: 2075-2086.
48. Kropf, P., D. Baud, S. E. Marshall, M. Munder, A. Mosley, J. M. Fuentes, C. R. Bangham, G. P. Taylor, S. Herath, B. S. Choi, et al. 2007. Arginase activity mediates reversible T cell hyporesponsiveness in human pregnancy. Eur. J. Immunol. 37: 935-945.
49. Vadillo-Ortega, F, O. Perichart-Perera, S. Espino, M. A. Avila-Vergara, I. Ibarra, R. Ahued, M. Godines, S. Parry, G. Macones, and J. F Strauss. 2011. Effect of supplementation during pregnancy with L - Arginine and antioxidant vitamins in medical food on pre-eclampsia in high risk population: randomised controlled trial. BMJ 342: d2901.
50. Agarwal, A., S. Gupta, L. Sekhon, and R. Shah. 2008. Redox considerations in female reproductive function and assisted reproduction: from molecular mechanisms to health implications. Antioxid. Redox Signal. 10: 1375-1403.
51. Agarwal, A., R. A. Saleh, and M. A. Bedaiwy. 2003. Role of reactive oxygen species in the pathophysiology of human reproduction. Fertil. Steril. 79: 829-843.
52. Woods, J. R., Jr. 2001. Reactive oxygen species and preterm premature rupture of membranes - A review. Placenta 22(Suppl. A): S38-S44.
53. Kusmartsev, S., and D. I. Gabrilovich. 2003. Inhibition of myeloid cell differentiation in cancer: the role of reactive oxygen species. J. Leukoc. Biol. 74: 186-196.
54. + T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species. J. Immunol. 172: 989-999.
55. + T cell tolerance in cancer. Nat. Med. 13: 828-835.
56. Corzo, C. A., M. J. Cotter, P. Cheng, F Cheng, S. Kusmartsev, E. Sotomayor, T Padhya, T. V. McCaffrey, J. C. McCaffrey, and D. I. Gabrilovich. 2009. Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells. J. Immunol. 182: 5693-5701.
57. Gabitass, R. F, N. E. Annels, D. D. Stocken, H. A. Pandha, and G W. Middleton. 2011. Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13. Cancer Immunol. Immunother. 60: 1419-1430.
58. Jeisy-Scott, V., W. G. Davis, J. R. Patel, J. B. Bowzard, W. J. Shieh, S. R. Zaki, J. M. Katz, and S. Sambhara. 2011. Increased MDSC accumulation and Th2 biased response to influenza A virus infection in the absence of TLR7 in mice. PLoS One 6: e25242.
59. Sinha, P., V. K. Clements, S. K. Bunt, S. M. Albelda, and S. Ostrand-Rosenberg. 2007. Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response. J. Immunol. 179: 977-983.
60. Chaouat, G. 2007. The Th1/Th2 paradigm: still important in pregnancy? Semin. Immunopathol. 29: 95-113.
61. Wilczynski, J. R. 2005. Th1/Th2 cytokines balance-yin and yang of reproductive immunology. Eur. J. Obstet. Gynecol. Reprod. Biol. 122: 136-143.
62. Svensson, L., M. Arvola, M. A. Sallstrom, R. Holmdahl, and R. Mattsson. 2001. The Th2 cytokines IL-4 and IL-10 are not crucial for the completion of allogeneic pregnancy in mice. J. Reprod. Immunol. 51: 3-7.
63. Marker-Hermann, E., and R. Fischer-Betz. 2010. Rheumatic diseases and pregnancy. Curr. Opin. Obstet. Gynecol. 22: 458-465.
64. Fischer-Betz, R., and E. Gromnica-Ihle. 2010. [Pregnancy and inflammatory rheumatic diseases]. Z. Rheumatol. 69: 633-641. doi:10.1007/s00393-010-0661-x
65. + immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host. Cancer Res. 66: 1123-1131.
66. Li, H., Y Han, Q. Guo, M. Zhang, and X. Cao. 2009. Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-p1. J. Immunol. 182: 240-249.
67. Flavell, R. A., S. Sanjabi, S. H. Wrzesinski, and P. Licona-Limon. 2010. The polarization of immune cells in the tumour environment by TGFp. Nat. Rev. Immunol. 10: 554-567.